MOUNTAINEER Trial: Rationale, Results and Clinical Implications
Subject matter expert discusses the impetus for and data from the MOUNTAINEER trial, touching on patient populations, study design, and key efficacy and safety endpoints.
EP: 1.Recent Advancements and Current Areas of Focus in the Treatment of mCRC
EP: 2.HER2 as a Potential Drug Target and its Prevalence in GI Malignancies
EP: 3.Biomarker Testing and Next-Generation Sequencing Inform Modern Treatment Strategies for mCRC
Now Viewing
EP: 4.MOUNTAINEER Trial: Rationale, Results and Clinical Implications
EP: 5.Promising Early Data from GI Malignancy Trials
Related Videos
Related Content
